Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Venous Thromboembolism

University College DublinSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Venous Thromboembolism cohort.

Asset / SponsorPhaseRating
Apixaban
Regeneron Pharmaceuticals
Phase 4BBB
FLUOROURACILUM
University College Dublin
Phase 4BBB
Calcium folinate pentahydrate
University College Dublin
Phase 4BBB
Acetylsalicylic Acid
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4BB
HEPARIN
Johns Hopkins University
Phase 4BB

View all 12 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →